- The notes have an initial conversion price of $9.25/shr (last $7.71).
- Company has also granted an option to the initial purchasers of the notes to purchase up to an additional $5.0M aggregate principal amount of notes to cover over-allotments.

Other headlines for [SLXP]

• SLXP 11/18/2008 12:31pm
  Salix Pharmaceuticals Ltd FDA extends review date by three months for Metozol- SLXP says extension has no impact on its previously announced financial guidance for 2008
  
• SLXP 11/18/2008 11:00am
  Salix Pharmaceuticals Ltd Announces issuance of U.S. Patent for Rifaximin- Provides protection relating to rifaximin for treating irritable bowel syndrome (IBS) caused by small intestinal bacterial overgrowth. - Salix has more...
  
• SLXP 11/5/2008 04:02pm
  Salix Pharmaceuticals Ltd Reports Q3 -$0.11 v -$0.31e, R $42.9M v $43.6Me- Guides FY08 -$0.90 v -$1.05e, R$178-180M v $176.3Me - Cash and cash equivalents were $121.9M on September 30, 2008.
  
• SLXP 10/31/2008 03:53pm
  Salix Pharmaceuticals Ltd APRISO Granted FDA Marketing Approval for Maintenance of Remission of Ulcerative Colitis- APRISO is the first and only 5-ASA with Intellicor extended release delivery technology. - The Company more...
  
• SLXP 10/9/2008 01:13pm
  Salix Pharmaceuticals Ltd Block of 1M shares trades at $7.00
  

Healthcare sector headlines

• CUR Today 08:02am
  Neuralstem Inc Collaborates with Hospital in Taiwan to Develop Additional ALS Stem Cell Clinical Trials- The collaboration will focus on Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's disease) with Dr. more...
  
• SVA Today 08:01am
  Sinovac Biotech Announces share buyback of up to $2M (5.5% of market cap)
  
• PRX Today 08:01am
  Par Pharmaceutical Companies Inc. Announces successful completion of Bioequivalence Studies for Ondansetron Thin Film- The ondansetron thin film product is being developed for the prevention of chemotherapy-induced nausea and more...
  
• CSKI Today 08:01am
  China Sky One Medical, Inc. Names Yu-Bo Hao new CFO- He replaces Yu-kun Zhang, who had served as interim CFO since June, 2008. - Mr. Hao has been employed at China Sky One in various capacities since June, 2008. - From more...
  
• THRX Today 08:01am
  Theravance Inc Announces positive Phase 2b results for LABA, '444 in the Horizon Asthma Development Programme with GSK- The study, which was designed to evaluate the efficacy of five doses of '444 administered more...